 |
|
UCB Group - Schwarz Pharma - Biopharmaceuticals, Neurology Drugs, Antiepilepsy, Antihistamine
|
| Stock Symbol UCB (Euronext Brussels)
|
Allee de la Recherche 60
Brussels (Belgium) B-1070
|
| |
|
| Phone: |
32.2.559.99.99 |
| Fax: |
32.2.559.95.71 |
| Company Description |
|
UCB Group 3.3 Billion Euro sales ($4.3 Billion US Dollars) over 10,000 employees, $5.6 Billion USD Sept 2006 acquisition of Schwarz Pharma, epilepsy pharmaceuticals, allergy respiratory antihistamine cough treatment |
|
|
|
